Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort-Reference-Cited by-同舟云学术

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort

Published:2011-09-09 Issue:9 Volume:6 Page:e23946
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Stoll Matthias,Kollan Christian,Bergmann Frank,Bogner Johannes,Faetkenheuer Gerd,Fritzsche Carlos,Hoeper Kirsten,Horst Heinz-August,van Lunzen Jan,Plettenberg Andreas,Reuter Stefan,Rockstroh Jürgen,Stellbrink Hans-Jürgen,Hamouda Osamah,Bartmeyer Barbara,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.;F Palella;New England Journal of Medicine,1998

2. The survival benefits of AIDS treatment in the United States.;R Walensky;The Journal of infectious diseases,2006

3. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.;R Hogg;Lancet,2008

4. German-Austrian Treatment Guidelines for antiretroviral therapy (Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion, Stand 4, März 2010).,2010

5. Guidelines for the Use of Antiretroviral Agents in HIV-1 infected Adults and Adolescents.,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study;Archives of Public Health;2023-08-25

2. Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019;BMC Health Services Research;2022-01-13

3. Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting;PLOS ONE;2022-01-13

4. Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study;Value in Health;2020-10

5. Updated direct costs of medical care for HIV‐infected patients within a regional population from 2006 to 2017;HIV Medicine;2019-12-18